Question

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

6 comments6

Total Forecasters36

Community Prediction60%

Make a Prediction

community: 59.7%

median 59.7%mean 58.3%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Food and Drug Administration

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Food and Drug Administration

Understanding Desire in the Age of Ozempic

Atlantic•Oct 1, 2024

The risks of taking Ozempic that are only now emerging and make me worry - even though it CAN be a weight loss fix, by DR EMILY LEEMING

Daily Mail•Oct 2, 2024

Lose weight FAST with this Ozempic alternative for a fraction of the cost - with free two-day delivery and no insurance required

Daily Mail•Oct 1, 2024

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

81%

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

MetaculusM

🚀Metaculus Open-Source Rewrite is Live!

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Make a Prediction

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Comments

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?